Latest Commercialization News

Pantera Minerals has seen a 37% uplift in the valuation of its EnergyX stake following an increase in EnergyX’s Regulation A raise price to US$13 per share, reflecting operational progress and stronger market confidence.

OD6 Metals has secured a strategic foothold in the US critical minerals market by acquiring the Quinn Fluorspar Project in Nevada, delivering ultra-high-grade assay results and commencing systematic exploration. Meanwhile, metallurgical progress at its Splinter Rock rare earths project and new copper targets at Gulf Creek underpin a diversified critical minerals portfolio.

Eagle Mountain Mining has formalised a joint venture with Nittetsu Mining for the Oracle Ridge copper project in Arizona, with Nittetsu committing US$20 million to advance exploration and development while managing the operation.

Xenitra Limited has swiftly moved from concept to commercial traction, generating over $100,000 in sales within the first week of launching EZZ Life Sciences products on its blockchain-based OPAL token ecosystem.

Great Divide Mining has transitioned its Challenger Gold Mine in NSW from commissioning to commercial production, targeting a gold concentrate grade of 30 grams per tonne from historic tailings with minimal capital expenditure.

Hiremii Limited has delivered its most profitable quarter yet, reporting record revenue and gross profit alongside its first positive adjusted EBITDA. The company also secured its first recurring SaaS contracts, marking a milestone in its shift towards a technology-driven workforce intelligence model.

VHM Limited has ditched its Shenghe Resources offtake agreement to broaden market options and approved a direct jump to full-scale 5Mtpa development at its Goschen Rare Earths and Mineral Sands Project. Key regulatory approvals and a major drilling campaign underpin progress towards a mid-2026 Final Investment Decision and production slated for late 2027.

Melbana Energy is poised to resume 100% ownership of its Cuban Block 9 after its partner Sonangol defaulted on US$23.5 million in cash calls. Fresh seismic data and well results have refined reservoir understanding, derisking future drilling plans.

AnteoTech (ASX: ADO) pushed forward its advanced battery and life sciences technologies in the March 2026 quarter, achieving key product validations and expanding its sales pipeline to record levels. The company ended the period with A$3.3 million cash and no debt following a recent A$3.5 million capital raise.

Nexalis Therapeutics has advanced its IRX-211 program by screening the first patient in a pivotal Phase 2 trial for Breakthrough Cancer Pain, aiming to address a significant unmet need in oncology supportive care.

RPM Automotive has appointed Roy Norris as its new CEO, replacing Clive Finkelstein who served since September 2024. Norris brings extensive industry experience aimed at steering RPM's strategic growth.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.